ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Published November 29, 2023 · Recall initiated: September 28, 2023
Summary
FDA records food Class III recall F-0463-2024, published November 29, 2023 and initiated September 28, 2023. Recalling firm: ActiPharma, Inc.; Status: Terminated; Reported quantity: 607 bottles of 100 tablets each; Lot: Lot 13309, Exp: 01/26. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ActiPharma, Inc.
- Distributor
- Domestic distribution, in Puerto Rico.
- UPC
- 363102217104
- Lot
- Lot 13309, Exp: 01/26
- Risk classification
- Class III
- Area (FDA)
- food
- Country
- United States
Related recalls
- FDAHEB Central Market Blueberry Buckwheat Gluten Free Waffle, 8.25oz, UPC 004122025365 Giant Eagle BlueberryNovember 29, 2023
- FDAAsenzya Hot & Spicy Cajun Style Seasoning, Item 121331. Net Wt 15 lbs. Distributed by: Asenzya 7616 SouthNovember 29, 2023
- FDALEADER brand Lubricant Eye Drops (Propylene Glycol, 0.6%); 0.33 FL OZ (10 mL) dropper bottles, Sterile,November 29, 2023
- FDAJeni's Splendid Ice Cream: Buttercream Birthday Cake Ice Cream packaged in paperboard pint cups with heatNovember 29, 2023
- FDALEADER brand Dry Eye Relief (Polyethylene Glycol 400, 0.4% Propylene Glycol, 0.3%); 0.33 FL OZ (10 mL) dropperNovember 29, 2023
- FDAGastroscope-endoscopic ultrasound (EUS) guided fine needle aspiration (FNA) and for endoscopic surgery withinNovember 29, 2023
Questions about this recall
Was ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104. recalled?
Yes. FDA published recall F-0463-2024 on November 29, 2023. Reported hazard: FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. UPC: 363102217104.